Published 2 days ago • loading... • Updated 17 hours ago
Africa: New TB Vaccines Could Save 7.3m Lives By 2050
Gavi said the vaccines could also unlock up to $135 billion in economic benefits across low- and middle-income countries by mid-century.
A fresh analysis from Gavi shows new tuberculosis vaccines could avert up to 7.3 million deaths from 2030 through 2050, while unlocking up to $135 billion in economic benefits across low- and middle-income countries.
Tuberculosis remains the world's leading infectious killer, claiming an estimated 1.23 million lives in 2024 according to the World Health Organisation. The only currently licensed vaccine, Bacille Calmette-Guerin, is over 100 years old and its protection wanes.
Sania Nishtar, head of the Gavi global vaccine alliance, called the pipeline vaccines the "next blockbuster immunisation tool". Success depends entirely on ensuring predictable, affordable supply for countries with the highest disease burden.
Gavi is working with partners now to lay groundwork for timely vaccine access. The organization intends to push for widespread routine immunization and "encourage a competitive and geographically diverse pipeline of novel TB vaccine candidates".
However, Gavi's analysis identified risks that could slow rollout. Inadequate global and domestic financing may limit uptake, while demand uncertainty could impact manufacturer capacity investments, creating supply risks for vulnerable nations.
The international Impfallianz Gavi expects a breakthrough in the development of new vaccines. The Trump administration removes requirements for greenhouse gas emissions from power plants. The DW news review.